CCDC50 Monoklonaler Antikörper
CCDC50 Monoklonal Antikörper für Indirect ELISA, WB
Wirt / Isotyp
Maus / IgG1
Getestete Reaktivität
human
Anwendung
Indirect ELISA, WB
Konjugation
Unkonjugiert
CloneNo.
2F12G7
Kat-Nr. : 68369-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
68369-1-PBS bindet in Indirect ELISA, WB CCDC50 und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Maus / IgG1 |
| Klonalität | Monoklonal |
| Typ | Antikörper |
| Immunogen | CCDC50 fusion protein Ag15889 |
| Vollständiger Name | coiled-coil domain containing 50 |
| Berechnetes Molekulargewicht | 482 aa, 56 kDa |
| Beobachtetes Molekulargewicht | 36-38 kDa |
| GenBank-Zugangsnummer | BC065004 |
| Gene symbol | CCDC50 |
| Gene ID (NCBI) | 152137 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-G-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
CCDC50 encodes Ymer, an effector of epidermal growth factor (EGF)-mediated cell signaling that is ubiquitously expressed in different organs and has been suggested to inhibit down-regulation of the EGF receptor. CCDC50 act as a multifunctional regulator in NF-κB and Fas signaling pathways. In chronic lymphocytic leukaemia (CLL) and mantle cell lymphoma (MCL), CCDC50 is required for the survival of MCL and CLL cancer cells. Recently, CCDC50 was shown to promote hepatocellular carcinoma through the Ras/Foxo4 signaling pathway. (PMID: 34453126, PMID: 32612200, PMID: 17503326)



